Blood cultures serve as the primary method for identifying which specific organism is causing a bloodstream infection, and that identification is what allows doctors to swap broad-spectrum antibiotics for targeted therapy that actually matches the bug. Despite being a test that dates back over a century, blood cultures remain the gold standard for diagnosing sepsis, though they come with real limitations: results take anywhere from one to seven days depending on the organism, and they miss a significant fraction of infections entirely.1PubMed Central. Culture-independent identification of bloodstream infections from whole blood: prospective evaluation in specimens of known infection status Understanding what blood cultures can and cannot do helps make sense of the decisions clinicians face when sepsis is on the table.
What Blood Cultures Actually Tell Clinicians
When someone develops sepsis, the immediate clinical response is to start broad-spectrum antibiotics quickly, often within an hour of recognition. That urgency is well justified since delays in treatment increase the risk of death. But broad-spectrum drugs are a blunt instrument. They hit many types of bacteria at once, which means they also kill beneficial organisms, promote resistance, and sometimes cause side effects that narrower drugs would avoid. Blood cultures exist to answer two questions: is there actually a bacterial or fungal pathogen in the bloodstream, and if so, which one?
Once a culture turns positive and the lab identifies the specific organism, the clinical team can narrow treatment. In one prospective study of ICU patients with positive blood cultures, switching from empirical antibiotics to therapy guided by culture results was associated with a meaningful drop in hospital mortality, from roughly 57% to 49%.2Frontiers in Pharmacology. Feasibility of De-Escalation Implementation for Positive Blood Cultures in Patients With Sepsis: A Prospective Cohort Study That kind of de-escalation is only possible when you know what you are treating. Without a culture result, clinicians are left guessing, and guessing tends to mean keeping patients on broader, more toxic regimens for longer than necessary.
Beyond species identification, the lab also runs susceptibility testing on the organism that grows. This tells clinicians exactly which antibiotics the pathogen is resistant to and which ones will work. Newer techniques can speed that step up considerably. One approach, known as rapid antimicrobial susceptibility testing performed directly from positive blood culture bottles, showed perfect agreement with standard methods across hundreds of samples of common gram-negative bacteria.3PubMed Central. Rapid bacterial identification by MALDI-TOF MS directly from blood cultures and rapid susceptibility testing: A simple approach to reduce the turnaround time of blood cultures Getting that resistance profile even a few hours earlier can change the trajectory of a patient’s illness.
Why Timing Matters So Much
The single biggest factor that determines whether a blood culture catches the offending organism is whether the sample is drawn before or after antibiotics are started. In a prospective study of patients with sepsis, cultures drawn before antibiotics were positive about 51% of the time, while those drawn after antibiotics had already been given were positive only about 28% of the time.4Clinical Microbiology and Infection. Impact of antibiotic administration on blood culture positivity at the beginning of sepsis: a prospective clinical cohort study That drop held for both gram-positive and gram-negative organisms.
A second study looked at this question in patients with severe sepsis specifically. Pre-antibiotic cultures were positive in about 31% of patients, while post-antibiotic cultures caught a pathogen in only about 19%. The sensitivity of cultures drawn after treatment began was roughly 53%, meaning they missed nearly half the infections that the pre-treatment cultures had found.5PubMed. Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis: A Diagnostic Study This is why sepsis guidelines emphasize drawing blood cultures before the first antibiotic dose whenever possible, even when the pressure to start treatment is intense.
In practice, that “before” window can be extremely narrow. A patient arriving in septic shock might have minutes, not hours, before antibiotics need to go in. The practical compromise is to draw cultures immediately at the point of recognition, then start antibiotics without waiting for the draw to be completed in both arms. Delaying antibiotics to wait for a perfect blood draw is not the trade-off anyone should make.
When Cultures Grow Skin Bacteria Instead of Pathogens
Blood cultures are drawn by puncturing a vein and transferring blood into specialized bottles. That process inevitably involves the needle passing through skin, which is colonized with bacteria. If even a small number of skin organisms get into the bottle, they can grow and produce a “positive” result that has nothing to do with the patient’s actual infection. This is called contamination, and it is one of the most persistent headaches in clinical microbiology.
The most common contaminants are coagulase-negative staphylococci, bacteria that live harmlessly on virtually everyone’s skin. In one study of blood cultures positive for these organisms, nearly three-quarters turned out to be contamination rather than true infection.6PubMed Central. Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients Yet physicians treated almost half those contaminated cultures with antibiotics anyway, often using vancomycin, a powerful drug best reserved for genuinely resistant infections. That unnecessary treatment added an estimated $1,000 per patient in costs at that facility alone.
Scaled across an entire hospital, the financial damage adds up fast. A systematic review found that contaminated blood cultures led to unnecessary antibiotic use in up to 59% of affected patients, increased laboratory charges by thousands of dollars per case, and extended hospital stays by anywhere from one to twenty-two days.7PubMed. Economic health care costs of blood culture contamination: A systematic review One hospital estimated that its 254 false-positive blood cultures in a single year added over 1,300 extra hospital days and nearly $1.9 million in avoidable costs.8Journal of Hospital Infection. Clinical and economic impact of contaminated blood cultures within the hospital setting The problem is not just wasted money. Every unnecessary day in the hospital is a day a patient is exposed to hospital-acquired infections, drug side effects, and immobility.
Efforts to reduce contamination focus on better skin antisepsis during blood draws and dedicated collection devices. One cost-benefit analysis found that using an initial specimen diversion device in the emergency department, which discards the first small volume of blood that may carry skin bacteria, could save about $272 per culture in overall hospital costs at facilities with higher baseline contamination rates.9PubMed Central. Estimated Clinical and Economic Impact through Use of a Novel Blood Collection Device To Reduce Blood Culture Contamination in the Emergency Department: a Cost-Benefit Analysis
Culture-Negative Sepsis
Roughly 40% of patients who meet clinical criteria for sepsis never have a pathogen identified on blood culture.10Clinical Chemistry. The Role of Procalcitonin in Diagnosis of Sepsis and Antibiotic Stewardship: Opportunities and Challenges That is a strikingly high miss rate for a gold-standard test, and the reasons behind it are varied.
Prior antibiotic exposure is one obvious cause: if the patient was already taking antibiotics for another reason before sepsis developed, the drug may have suppressed the bacteria enough to prevent growth in the bottle. Insufficient blood volume, poor transport conditions, and fastidious organisms that simply do not grow well in standard culture media all contribute as well. Molecular techniques like PCR can sometimes detect bacterial DNA in patients whose cultures come back empty, which suggests that the infection is real even when the culture cannot catch it.11PubMed Central. Characteristics and outcomes of culture-negative versus culture-positive severe sepsis
There is also a growing recognition that some cases diagnosed clinically as sepsis are not bacterial at all. Viral infections, certain fungal infections, inflammatory conditions, drug reactions, and even some cancers can mimic the systemic inflammatory response that defines sepsis. In those cases, blood cultures are negative because there is no bacterium to find.12PubMed Central. Characteristics and clinical outcomes of culture-negative and culture-positive septic shock: a single-center retrospective cohort study One hypothesis is that culture-negative sepsis often reflects a lower bacterial burden or a milder infectious insult, which may partly explain why some studies report slightly better outcomes in culture-negative patients compared to culture-positive ones.
How the Speed of Growth Tells Its Own Story
Once a blood culture bottle is loaded into the automated incubator, the machine monitors it continuously for signs of microbial growth. The interval between when the bottle is loaded and when it flags positive is called the time to positivity, and it turns out to carry real prognostic information beyond just identifying the organism.
A systematic review and meta-analysis found that patients whose blood cultures turned positive quickly had nearly three times the odds of dying compared to those with slower-growing cultures. The odds of developing septic shock were even higher, roughly fourfold, in the fast-growing group.13PubMed Central. Short time to positivity of blood culture predicts mortality and septic shock in bacteremic patients: a systematic review and meta-analysis The logic is intuitive: a bottle that flags in just a few hours likely started with a higher concentration of bacteria in the patient’s blood, which signals a more overwhelming infection.
The relationship between speed and outcome is not identical across all organisms, though. For Staphylococcus aureus, one study found that a time to positivity longer than 24 hours was actually linked to higher 30-day mortality, the opposite of the general pattern. For many other common pathogens, including streptococci, enterococci, and the major gram-negative families, the association was not significant.14PubMed. Relationship between blood culture time to positivity, mortality rate, and severity of bacteremia So time to positivity is a useful signal, but interpreting it requires knowing what organism eventually grew.
Getting the Sample Right
A standard blood culture order involves drawing blood from two separate sites and splitting each draw between an aerobic bottle and an anaerobic bottle. That pairing is not arbitrary. Aerobic bottles are optimized for organisms that thrive in oxygen, while anaerobic bottles support bacteria that grow without it. But the anaerobic bottle does more than catch rare anaerobic infections.
A large study found that if hospitals had collected only aerobic bottles, they would have missed over 2,000 positive cultures and more than 7,400 isolates, including clinically important organisms like Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli.15PubMed Central. Routine Use of Anaerobic Blood Culture Bottles for Specimens Collected from Adults and Children Enhances Microorganism Recovery and Improves Time to Positivity This happens because many common bacteria are “facultative” — they can grow with or without oxygen — and some of them actually grow faster or more reliably in the anaerobic bottle. Staphylococcus aureus, for instance, showed both higher recovery rates and quicker detection times in anaerobic bottles than in aerobic ones. A separate real-world evaluation confirmed that about 17% of pathogenic isolates grew exclusively in the anaerobic bottle, and in half those cases, the finding changed the patient’s antibiotic therapy.16PubMed. Real-life evaluation of supplemental anaerobic blood culture bottles: impact on diagnosis and therapeutic management of patients with suspected sepsis
Blood volume also matters. The more blood you put in the bottle, the more bacteria you capture, and studies have consistently shown that higher volumes improve detection. For critically ill patients with high severity scores, each additional milliliter of blood increased the odds of detecting bacteremia.17PubMed Central. Is the volume of blood cultured still a significant factor in the diagnosis of bloodstream infections? The challenge is that the sickest patients often have the worst veins and the hardest blood draws, which means the patients who need the highest volume are the ones most likely to have underfilled bottles.
Pediatric and Neonatal Draws
Children and especially newborns pose a unique challenge. You cannot safely draw 20 to 30 milliliters from a premature infant. Current recommendations suggest as little as 1 to 1.5 milliliters for infants weighing under about 11 kilograms and around 7.5 milliliters for children in the 11 to 17 kilogram range.18Clinical Microbiology and Infection. The correct blood volume for paediatric blood cultures: a conundrum? Even those smaller volumes are hard to hit reliably. A feasibility trial in neonates found that while about 87% of samples met the adequacy threshold, nurses’ visual estimates of the volume they had collected were often wrong: more than 84% of inadequate samples were judged by the person drawing the blood to be adequate.19PubMed Central. Point-of-Care Verification of Blood Culture Volume in Neonates: A Feasibility Trial This suggests that point-of-care volume verification, such as weighing the bottle before and after, could meaningfully improve neonatal blood culture performance.
When Patients Are Already on Antibiotics
Because sepsis frequently develops in hospitalized patients who are already receiving antibiotics for something else, laboratories have developed ways to counteract the drug’s presence in the blood sample. Many modern blood culture bottles contain resin beads that bind to antibiotic molecules and neutralize them, giving any bacteria present a better chance of growing. Studies have shown that these resins can reduce antibiotic activity in the bottle by 80 to 90% within two hours.20PubMed Central. Effectiveness of resins in neutralizing antibiotic activities in bactec plus Aerobic/F culture medium
Not all resin formulations perform equally, however. A head-to-head comparison of three different blood culture systems found major differences in recovery rates when common antibiotics were present: a system with a newer resin formulation recovered organisms in about 88% of antibiotic-spiked samples, compared to 43% for a standard resin system and just 13% for a system that relied on dilution alone.21PubMed Central. Comparison and evaluation of neutralization of clinically frequently used antimicrobial agents using three different culture media in simulated blood cultures For patients already receiving treatment, the choice of blood culture bottle can genuinely affect whether the lab finds anything.
Fungal Bloodstream Infections
Standard blood culture bottles were designed primarily for bacteria, and they do a mediocre job with fungi. Candida species, the most common cause of fungal bloodstream infections, are detected by blood culture only about half the time, with sensitivity estimates ranging from 21% to 71% depending on the clinical scenario.22PubMed Central. Diagnostic Biomarkers for Invasive Candidiasis: A Clinician-Oriented Review Deep-seated infections where Candida is lodged in tissue rather than free-floating in the blood are especially likely to be missed.
Newer molecular panels can detect Candida DNA directly in the blood without waiting for growth, but their real-world performance has not always matched initial expectations. One evaluation at an academic medical center found that a rapid Candida detection panel had a specificity of about 96% but a sensitivity of only 65%, and its positive predictive value was just 41%.23PubMed Central. Evaluation of a Rapid Fungal Detection Panel for Identification of Candidemia at an Academic Medical Center The takeaway for clinicians is that a negative result on one of these panels does not rule out candidemia, and cultures (sometimes specialized fungal culture bottles) remain part of the workup when fungal infection is suspected.
Polymicrobial Infections
Most bloodstream infections involve a single organism, but somewhere around 10 to 14% grow two or more pathogens from the same blood culture episode.24Infection and Drug Resistance. Microbiological Analysis and Mortality Risk Factors in Patients with Polymicrobial Bloodstream Infections These polymicrobial infections are harder to treat and carry worse outcomes. In neonatal intensive care, polymicrobial bloodstream infections were associated with more than a threefold increase in mortality compared to infections caused by a single organism.25PubMed Central. Polymicrobial bloodstream infections in the neonatal intensive care unit are associated with increased mortality: a case-control study
Conventional blood cultures can struggle with polymicrobial samples because one fast-growing organism may dominate the bottle and mask the presence of slower-growing species. Molecular methods that detect microbial DNA directly, rather than relying on competitive growth in a bottle, are an active area of research aimed at improving detection of these mixed infections.26PubMed Central. Molecular Methodologies for Improved Polymicrobial Sepsis Diagnosis For now, clinicians need to maintain a high index of suspicion for mixed infections in patients with certain risk factors, particularly those with central venous catheters, recent surgery, or prolonged ICU stays.
Diagnosing Catheter-Related Infections
Patients with central venous catheters face a distinct diagnostic puzzle: when their blood culture comes back positive, is the infection coming from the catheter itself or from somewhere else in the body? The answer matters because catheter-related infections often require removing the line, while bloodstream infections from another source do not.
The technique used to sort this out is called differential time to positivity. Blood is drawn simultaneously from the catheter and from a separate vein in the arm. If the catheter sample flags positive at least two hours before the peripheral sample, the catheter is the likely source. A meta-analysis of this approach found a sensitivity of about 81% and a specificity of about 92% for diagnosing catheter-related bloodstream infections.27PubMed. Utility of Differential Time to Positivity in Diagnosing Central Line-Associated Bloodstream Infections: A Systematic Review and Meta-Analysis The logic is straightforward: if bacteria are colonizing the catheter, the sample drawn through it will have a higher starting concentration and grow faster.
The technique works best for short-term catheters. For long-term catheters, the numbers shift: sensitivity rises to about 93%, but specificity drops to around 75%.28PubMed. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections And for hemodialysis catheters specifically, the criteria are met in fewer than a third of cases, which limits the method’s usefulness in that population.29PubMed Central. Evaluating Approaches for the Diagnosis of Hemodialysis Catheter-Related Bloodstream Infections
Procalcitonin as a Companion Test
Blood cultures tell you what organism is present; they do not tell you whether antibiotics should be continued or stopped in the days that follow. Procalcitonin, a blood marker that rises in response to bacterial infection and falls as the infection resolves, has emerged as a useful companion test for guiding those later decisions. It helps clinicians decide when to stop antibiotics, which is arguably as important as deciding when to start them.30PubMed Central. Role of procalcitonin use in the management of sepsis
The evidence is strongest in newborns with suspected early-onset sepsis. A randomized trial found that using procalcitonin levels to guide treatment decisions safely reduced antibiotic duration by roughly 10 to 13 hours compared to standard care, with no sepsis-related deaths and a very low rate of re-infection.31The Lancet. Procalcitonin-guided decision making to reduce antibiotic therapy in neonates with suspected early-onset sepsis (NeoPInS): a randomised controlled trial Procalcitonin does not replace blood cultures — it answers a different question — but the two tests together give a more complete picture than either one alone.
Ordering Blood Cultures More Wisely
There is a growing push in hospitals to order blood cultures only when they are genuinely indicated, rather than reflexively with every fever spike. Unnecessary cultures drive up costs, increase the number of contaminated results that trigger wasteful workups, and contribute to antibiotic overuse. Diagnostic stewardship programs that educate clinicians on appropriate indications for ordering cultures have shown they can reduce blood culture rates by 15 to 30% without any worsening in sepsis detection or patient mortality.32PubMed Central. A Diagnostic Stewardship Intervention To Improve Blood Culture Use among Adult Nonneutropenic Inpatients: the DISTRIBUTE Study One such program also demonstrated a reduction in overall antibiotic use alongside its lower culture rates.33Antimicrobial Stewardship & Healthcare Epidemiology. The impact of a blood-culture diagnostic stewardship intervention on utilization rates and antimicrobial stewardship
Machine learning tools are beginning to play a role here too. A prediction model tested prospectively in emergency departments identified at least 30% of patients in whom blood cultures could have been safely withheld, which would reduce the number of false positives and the downstream costs they generate.34eBioMedicine. Diagnostic stewardship for blood cultures in the emergency department: A multicenter validation and prospective evaluation of a machine learning prediction tool The goal is not to draw fewer cultures in patients who actually need them but to stop drawing them in patients who clearly do not, like someone with a viral upper respiratory infection and no signs of systemic illness. Fewer unnecessary cultures mean fewer contaminants, fewer unnecessary antibiotics, and lower costs — without missing genuine infections.